Literature DB >> 3593662

A study of serum thiocyanate concentrations in office workers as a means of validating smoking histories and assessing passive exposure to cigarette smoke.

A S Robertson, P S Burge, B L Cockrill.   

Abstract

Patients in clinical practice often falsely report their smoking status. To see if this was so in occupational surveys we have validated smoking histories (using a serum thiocyanate assay) in 206 randomly sampled office workers who completed a smoking questionnaire administered by a doctor. Past and present cigarette consumption was determined with an assessment of exposure to passive cigarette smoke at home and at work in the non-smokers. Serum thiocyanate concentrations were measured by the ferric nitrate method. All smoking groups showed mean thiocyanate concentrations greater than non-smokers except those smoking five or fewer cigarettes a day. There was a significant increase in plasma thiocyanate with increasing smoking (p less than 0.01). Non-smokers with and without exposure to passive smoke could not be separated by thiocyanate concentration. In our hands serum thiocyanate concentrations identified moderate and heavy smokers but could not distinguish between non-smokers, light smokers, and passive smokers. Fourteen non-smokers had serum thiocyanate concentrations higher than 70 mumol/l which were still raised on a repeat sample. On a further questionnaire two admitted to smoking. To help confirm non-smoking status, expired carbon monoxide levels were also checked in this group. One person had a level of 22 ppm and subsequently admitted to smoking. In the others the levels were less than or equal to 10 ppm. Using a combination of serum thiocyanate assay and exhaled breath carbon monoxide levels, non-smoking was confirmed in 98% of those stating that they were non-smokers. In non-smokers exposure to passive cigarette smoke was much more likely to occur at work than at home.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593662      PMCID: PMC1007833          DOI: 10.1136/oem.44.5.351

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  12 in total

1.  The determination of thiocyanate in blood serum.

Authors:  R G Bowler
Journal:  Biochem J       Date:  1944       Impact factor: 3.857

2.  Changes in serum thiocyanate concentration on stopping smoking.

Authors:  B Junge
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-06

3.  Two automated methods for measuring plasma thiocyanate compared.

Authors:  C J Vesey; C J Kirk
Journal:  Clin Chem       Date:  1985-02       Impact factor: 8.327

4.  Urinary cotinine as marker of breathing other people's tobacco smoke.

Authors:  N J Wald; J Boreham; A Bailey; C Ritchie; J E Haddow; G Knight
Journal:  Lancet       Date:  1984-01-28       Impact factor: 79.321

5.  Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements.

Authors:  R G Wilcox; J Hughes; J Roland
Journal:  Br Med J       Date:  1979-10-27

6.  Absorption of nicotine and carbon monoxide from passive smoking under natural conditions of exposure.

Authors:  M J Jarvis; M A Russell; C Feyerabend
Journal:  Thorax       Date:  1983-11       Impact factor: 9.139

7.  Improved 125I radioimmunoassay for cotinine.

Authors:  S R Jones; S Amatayakul
Journal:  Clin Chem       Date:  1985-06       Impact factor: 8.327

8.  Carboxyhaemoglobin and plasma thiocyanate: complementary indicators of smoking behaviour?

Authors:  Y Saloojee; C J Vesey; P V Cole; M A Russell
Journal:  Thorax       Date:  1982-07       Impact factor: 9.139

9.  Expired air carbon monoxide and serum thiocyanate as objective measures of cigarette exposure.

Authors:  T M Vogt; S Selvin; G Widdowson; S B Hulley
Journal:  Am J Public Health       Date:  1977-06       Impact factor: 9.308

10.  Nicotine concentrations in urine and saliva of smokers and non-smokers.

Authors:  C Feyerabend; T Higenbottam; M A Russell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-03
View more
  6 in total

1.  Electrophysiological impact of thiocyanate on isolated mouse retinal pigment epithelial cells.

Authors:  Xu Cao; Connor Baharozian; Bret A Hughes
Journal:  Am J Physiol Cell Physiol       Date:  2019-03-20       Impact factor: 4.249

Review 2.  Deception in clinical trials and its impact on recruitment and adherence of study participants.

Authors:  Chuen Peng Lee; Tyson Holmes; Eric Neri; Clete A Kushida
Journal:  Contemp Clin Trials       Date:  2018-08-21       Impact factor: 2.226

3.  SLC26A7 constitutes the thiocyanate-selective anion conductance of the basolateral membrane of the retinal pigment epithelium.

Authors:  Xu Cao; Manoocher Soleimani; Bret A Hughes
Journal:  Am J Physiol Cell Physiol       Date:  2020-07-29       Impact factor: 4.249

4.  Relationship between cigarette smoking and hypothyroidism in patients with Hashimoto's thyroiditis.

Authors:  S Fukata; K Kuma; M Sugawara
Journal:  J Endocrinol Invest       Date:  1996-10       Impact factor: 4.256

5.  The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases.

Authors:  Yanping Xu; Szilvia Szép; Zhe Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

6.  Melatonin attenuates thiocyanate-induced vasoconstriction in aortic rings.

Authors:  Alexander M Prusa; Christian A Plass
Journal:  Saudi Pharm J       Date:  2017-03-25       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.